Selective immunoglobulin A deficiency

Selective immunoglobulin A deficiency
The dimeric IgA molecule. 1 H-chain, 2 L-chain, 3 J-chain, 4 secretory component
ICD-10	D80.2
ICD-9	279.01
OMIM	137100
DiseasesDB	29569
MedlinePlus	001476
eMedicine	med/1159

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Selective immunoglobulin A (IgA) deficiency is a relatively mild genetic immunodeficiency. People with this deficiency lack immunoglobulin A (IgA), a type of antibody that protects against infections of the mucous membranes lining the mouth, airways, and digestive tract. It is defined as an undetectable serum IgA level in the presence of normal serum levels of IgG and IgM. It is the most common of the primary antibody deficiencies.

Epidemiology and Demographics

Prevalence varies by population, but is on the order of 1 in 500 to 1 in 800 people, making it relatively common for a genetic disease.

Natural History, Complications, and Prognosis

Prognosis

Prognosis is excellent, although there is an association with autoimmune disease. Of note, selective IgA deficiency can complicate the diagnosis of one such condition, celiac disease, as the deficiency masks the high levels of certain IgA antibodies usually seen in celiac disease.

Diagnosis

History and Symptoms

People with selective IgA deficiency are asymptomatic, or have increased frequency of infections such as sinusitis. These infections are generally mild and would not usually lead to an in-depth workup except when unusually frequent. When suspected, the diagnosis can be confirmed by laboratory measurement of IgA level in the blood. Patients have an increased susceptibility to pneumonia and recurrent episodes of other respiratory infections and a higher risk of developing autoimmune diseases in middle age.

Treatment

Medical Therapy

The treatment consists of identification of comorbid conditions, preventive measures to reduce the risk of infection, and prompt and effective treatment of infections. Infections in an IgA-deficient person are treated as usual (i.e., with antibiotics). There is no treatment for the underlying disorder (except for bone marrow transplant, which is far too drastic to be used). In the absence of normal IgA, the body can develop an immune response against IgA itself (anti-IgA antibodies), which can lead to severe reactions including anaphylaxis to blood transfusions or intravenous immunoglobulin. Therefore, people known to have this condition must notify their healthcare providers. Since this is a genetic condition, careful discussion should be undertaken prior to having children.